Proton pump inhibitor (PPI) use is associated with incident chronic kidney disease (CKD), according to new findings. Lazarus and et al. studied the effects of PPIs in 10,484 participants of the Atherosclerosis Risk in Communities study, and found that twice-daily PPI dosing was associated with a higher risk of CKD than once-daily dosing. As PPIs are one of the most commonly used drugs worldwide, the researchers propose that future studies should investigate whether limiting PPI use will reduce the incidence of CKD.
References
Lazarus, B. et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2015.7193
Rights and permissions
About this article
Cite this article
Edwards, J. Proton pump inhibitors increase risk of CKD. Nat Rev Nephrol 12, 126 (2016). https://doi.org/10.1038/nrneph.2016.12
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2016.12